BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36834564)

  • 1. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
    John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
    Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
    Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
    Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
    Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
    Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of Thyroid Tumors Based on DNA Methylation Patterns.
    Marczyk VR; Recamonde-Mendoza M; Maia AL; Goemann IM
    Thyroid; 2023 Sep; 33(9):1090-1099. PubMed ID: 37392021
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Mostoufi-Moab S; Labourier E; Sullivan L; LiVolsi V; Li Y; Xiao R; Beaudenon-Huibregtse S; Kazahaya K; Adzick NS; Baloch Z; Bauer AJ
    Thyroid; 2018 Jan; 28(1):60-67. PubMed ID: 29108474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intratumor microbiome predicts prognosis across gender and subtypes in papillary thyroid carcinoma.
    Gnanasekar A; Castaneda G; Iyangar A; Magesh S; Perez D; Chakladar J; Li WT; Bouvet M; Chang EY; Ongkeko WM
    Comput Struct Biotechnol J; 2021; 19():1986-1997. PubMed ID: 33995898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary Thyroid Carcinoma Variants are Characterized by Co-dysregulation of Immune and Cancer Associated Genes.
    Chakladar J; Li WT; Bouvet M; Chang EY; Wang-Rodriguez J; Ongkeko WM
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31443155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.
    Wahid MHA; Almudhafar RH
    J Med Life; 2022 Apr; 15(4):520-525. PubMed ID: 35646190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of
    Kim H; Kim BH; Kim YK; Kim JM; Oh SY; Kim EH; Lee MJ; Kim JH; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
    J Korean Med Sci; 2018 Jul; 33(27):e75. PubMed ID: 29962924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
    Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
    Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
    Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.